HeRO Seminar: Jianyi (Jay) Zhang, MD, PhD 5/9/17
Location: Health Sciences Research Building (HSRB) Auditorium
LEARNING OBJECTIVES: Transplantation of engineered tissue patches with either progenitor cells or cardiomyocytes for cardiac repair is emerged as an exciting treatment option for post infarction LV remodeling. Beneficial effects may be due to direct remuscularization or paracrine mechanisms leading to mobilization and/or activation of endogenous progenitors with subsequent promotion of neovascularization, remuscularization and inhibition of apoptosis, and thus attenuation of disease progression.
Participants will be able to discuss and explain the current understanding the major roadblocks in cardiac cell therapy, and the potential approaches to overcome these problems. One of the major objective is to make the cell products become the treatment options in the future. Participants will also share their knowledge and interests in pursuing the novel applications in this emerging field of tissue engineering and cell therapy.
Reception to follow in the HSRB Cafe.